Top Markets
#1 Islamic Coin Islamic Coin +151.45%
#2 DOVU DOVU +50.49%
#3 Black Phoenix Black Phoenix +34.88%
#4 Velvet Velvet +32.10%
#5 Akedo Akedo +21.65%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.03%
#7 DoubleZero DoubleZero +15.69%
#8 Cross Cross +12.56%
#9 HOME HOME +12.51%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.12%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
PolarityTE, Inc. PolarityTE, Inc.

PolarityTE, Inc.

PTE
Rank in Stocks #39868
Based in Salt Lake City, Utah, PolarityTE, Inc. is a clinical-stage... Based in Salt Lake City, Utah, PolarityTE, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of regenerative tissue products and biomaterials. Its offerings serve the medical, biomedical engineering, and material sciences sectors across the United States. The company operates through two primary divisions: Regenerative Medicine Products and Contract Services. PolarityTE's key product is SkinTE, a specialized tissue solution employed for the repair, reconstruction, replacement, or augmentation of skin in patients. Its applications encompass treating acute or chronic wounds, burns, surgical reconstruction, scar revision, and the removal of dysfunctional skin grafts. In addition to its product line, the firm also provides contract research services. The company's pipeline includes SkinTE Cryo, which facilitates multiple deployments from a single harvest through a cryopreservation process, and a SkinTE point-of-care device designed for immediate processing and application of SkinTE directly after initial harvest. PolarityTE is also advancing PTE 11000, an allogenic, biologically active dressing engineered to accelerate healing in both wound care and aesthetic contexts, alongside other promising tissue regeneration products.
Share Price
$0.241
Last synced: 2023-06-15
Market Cap
$318.31K
Change (1 day)
-0.82%
Change (1 year)
0.00%
Country
US
Trade PolarityTE, Inc. (PTE)

Category

Healthcare
Revenue for PolarityTE, Inc. (PTE)
Revenue in Aug 2026 TTM: 0
According to PolarityTE, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for PolarityTE, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE